Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Review

Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation

Free

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

	Abstract	Full	Pdf
Dec 2019	5	5	0
Jan 2020	8	8	1
Feb 2020	8	8	1
Mar 2020	19	19	1
Apr 2020	21	21	6
May 2020	13	13	1
Jun 2020	12	12	5
Jul 2020	14	14	3
Aug 2020	3	3	5
Sep 2020	24	24	4
Oct 2020	26	26	6
Nov 2020	10	10	4
Dec 2020	25	25	2
Jan 2021	31	30	8
Feb 2021	34	34	4
Mar 2021	13	13	2
Apr 2021	5	5	0
May 2021	4	4	6
Jun 2021	13	13	4
Jul 2021	15	15	6
Aug 2021	11	11	4
Sep 2021	8	8	4
Oct 2021	19	19	10
Nov 2021	9	9	2
Dec 2021	7	7	2
Jan 2022	14	16	1
Feb 2022	13	14	2
Mar 2022	23	23	7
Apr 2022	26	27	8
May 2022	33	34	11
Jun 2022	31	32	2
Jul 2022	24	24	5
Aug 2022	30	30	3
Sep 2022	33	33	13
Oct 2022	26	27	3
Nov 2022	8	8	4
Dec 2022	9	9	2
Jan 2023	9	9	3
Feb 2023	28	28	4
Mar 2023	6	8	10
Apr 2023	8	8	3
May 2023	7	7	7
Jun 2023	18	18	2
Jul 2023	6	6	3
Aug 2023	20	20	11
Sep 2023	6	6	10
Oct 2023	18	18	6
Nov 2023	47	47	6
Dec 2023	110	110	75
Jan 2024	21	22	89
Feb 2024	12	12	2
Mar 2024	13	13	47
Total	956	965	430